Man Group PLC Mustang Bio, Inc. Transaction History

Man Group PLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.58 - $1.13 $6,160 - $12,002	10,622 New	10,622 $6,000
Q2 2021 Aug 16, 2021	SELL	$2.7 - $3.81 $181,483 - $256,092	-67,216 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$3.02 - $5.16 $202,992 - $346,834	67,216 New	67,216 $223,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $22.1M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.